Plain-English translation of NCT07325552 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing two different surgical approaches for patients who have both glaucoma (high eye pressure) and cataracts (clouding of the lens). One approach uses the iStent Inject W device, a tiny implant that helps fluid drain from the eye, combined with cataract surgery. The other approach uses the Kahook Dual Blade, a specialized surgical tool that creates a new drainage pathway in the eye, also combined with cataract surgery. Both treatments aim to lower eye pressure and reduce your need for glaucoma medications.
Many patients with glaucoma also develop cataracts and need surgery for both conditions. This trial exists to determine which surgical technique โ when combined with cataract removal โ works better at controlling eye pressure and reducing medication dependence in the long term.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will be randomly assigned to one of two surgical groups. You will undergo cataract surgery combined with either the iStent Inject W implant or the Kahook Dual Blade procedure โ whichever your group receives. You will need to attend follow-up visits after surgery so your eye doctor can monitor your eye pressure, healing, and whether your eye pressure medications can be reduced. The study involves only one eye per participant.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Poland
Sponsor
Medical University of Bialystok
Enrollment target
~100 participants
Started
January 2026
Primary completion
January 2027
Age range
18 Weeks and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Joanna Konopinska
Medical University of Bialystok
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.